SCHEMBL6983205

SCHEMBL6983205

Nc1nc(N)nc(-c2ccc(Oc3ccccc3)cc2)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.70
BRAF P15056 1/20 0.70
POLB P06746 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
ADORA2A P29274 1/20 0.67
ADORA2B P29275 1/20 0.67
ADORA1 P30542 1/20 0.67
HPGD P15428 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
ALDH1A1 P00352 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2C9 P11712 1/20 0.66
CYP2C19 P33261 1/20 0.66
MEN1 O00255 1/20 0.63
MAPT P10636 1/20 0.63
KMT2A Q03164 1/20 0.63
DHFR P00374 3/20 0.58
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
MAOA P21397 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030097 0.84 HSP90AA1 (0.74) IKBKBBRAFPOLBADORA3ADORA2A
SCHEMBL21887691 0.84 MAPK1 (0.58) IKBKBBRAFHPGDALDH1A1CYP1A2
SCHEMBL30046504 0.83 ADORA2A (0.56) IKBKBBRAFADORA2AADORA1HPGD
SCHEMBL13779344 0.83 SMN1; SMN2 (0.71) IKBKBBRAFPOLBADORA3ADORA2A
SCHEMBL11800259 0.82 MAOA (0.65) IKBKBBRAFPOLBADORA3ADORA2A
SCHEMBL8524606 0.81 ADORA2A (0.62) IKBKBBRAFPOLBADORA3ADORA2A
SCHEMBL20220186 0.81 MAPK1 (0.55) IKBKBBRAFPOLBADORA3ADORA2A
SCHEMBL6977514 0.81 ADORA1 (0.91) IKBKBBRAFPOLBADORA3ADORA2A
Benzoguanamine SCHEMBL28634836 0.81 ADORA2A (1.00) IKBKBBRAFPOLBADORA3ADORA2A
Benzoguanamine SCHEMBL27898 0.81 ADORA2A (1.00) IKBKBBRAFPOLBADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP disclosed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO disclosed